Wellmune WGP, a gluco polysaccharide, clinically proven to safely prime key immune cells, significantly reduced duration of URTI symptoms among medical students during the cold-flu season. Derived from a proprietary strain of yeast, Wellmune mobilizes neutrophils, which are part of the body's first line of defense. Several clinical studies demonstrate the protective effects of Wellmune WGP for individuals during cold-flu season or periods of stress. Wellmune is available in dispersive and soluble form, ideal for any food or beverage. Wellmune is part of the prestigious EU-study "FibeBiotics".